2026 H1 - tulosraportti
60 päivää sitten
‧45 min
Tarjoustasot
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä |
|---|---|---|
| 3 193 | ||
| 1 | ||
| 4 695 | ||
| 1 | ||
| 1 880 |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Rahastoja ja ETF:iä jotka omistavat osaketta
Mikään rahasto ei ilmoita osaketta kymmenen suurimman omistuksensa joukossa.
Asiakkaat katsoivat myös
Yhtiötapahtumat
Datan lähde: Quartr| Seuraava tapahtuma | |
|---|---|
2026 H2 - tulosraportti 26.2.2027 |
| Menneet tapahtumat | ||
|---|---|---|
2026 H1 - tulosraportti 28.8. | ||
2025 H2 - tulosraportti 26.2. | ||
2025 H1 - tulosraportti 29.8.2025 | ||
2024 H2 - tulosraportti 26.2.2025 | ||
2024 H1 - tulosraportti 30.8.2024 |
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Foorumi
Liity keskusteluun Nordnet Socialissa
·23 min sittenLast time I jump into a Rights Issue. Glad I only got 1/3 of the ones I wanted. Good figures in February must mean an upward trend. Think Thor has complete control. Break Even 2027:)
·1 t sitten · MuokattuIt stated in the press release that the first deliveries to MDC have already been made. Meaning several deliveries already. Then thor also has a number of other partners they most likely have delivered to in addition, could it be that they have a better ramp-up than planned? That remains to be seen..
You come with some good questions but no answers, but the questions are an important point for Thor Medical's future. Here below is what I have been able to find regarding their capacity: Right now, Thor Medical has about 25 % vacant space left in the first phase of their new factory, after having secured their first major customers. But they have made a couple of brilliant moves that mean they do not risk hitting the wall at all if a giant like Eli Lilly suddenly wants an agreement. They have secured extra space in two ways: They built the factory 40 % larger from the start: When management discovered how large the demand was, they expanded the factory immediately right in the middle of construction. This means that they have a solid buffer standing ready for new customers. The factory grows all by itself because Thor Medical's technology is arranged so smartly that as the raw material "Thorium" lies and works over time, the factory's production increases completely automatically. The output actually grows from 21,000 doses a year to 35,000 doses after 5 years – completely without them having to rebuild or spend more money. They can easily build more factories if a giant like Eli Lilly places an order that is so enormous that the factory in Norway cannot keep up. So there is plenty of space in the shop, and the machinery is geared to welcome the big boys in the class from day one. It is good news that management has taken into account to avoid internal bottlenecks. https://www.thormedical.com/artikler/thor-medical-asa-first-half-2026-results---alphaone-operational-entering-commercial-ramp-up- ·2 t sittenThor makes haste slowly, bought at 4.10 yesterday, bought with an equally light hand at 4.26 today. Supports a previous post here that mentioned that all purchases in the 4s will entail marginal risk..BUT that assumes one possesses the new superpower..Thormodiness ☝️ (It should really go without saying if you look at my portfolio, but mentioning it anyway, the above must not be seen as a recommendation to buy 😅)Spm: Will we be able to experience DNB changing its target price and recommendation without positive news having been communicated regarding the USA case? What would in that case be the triggering factor? (Asking for a friend 🫣)
·4 t sittenPeople who complain about poor communication and little news should check out the quote that Ballon d'Or winner Harry Kane shared on his insta story. Have a nice day.
In the previous interview with Finansavisen, one of the journalists says that breaking into the US is not easy and that it must be a matter of partnerships or the like. Could it be that they are playing their cards close to their chest until this is 100% or that they have underestimated the complexity of breaking into the US? Betting on the first. At the end of the day it does not matter all that much, but they need to get to Boston shortly.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tuotteita joiden kohde-etuutena tämä arvopaperi
Välittäjätilasto
Dataa ei löytynyt
2026 H1 - tulosraportti
60 päivää sitten
‧45 min
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Foorumi
Liity keskusteluun Nordnet Socialissa
- ·23 min sittenLast time I jump into a Rights Issue. Glad I only got 1/3 of the ones I wanted. Good figures in February must mean an upward trend. Think Thor has complete control. Break Even 2027:)
- ·1 t sitten · MuokattuIt stated in the press release that the first deliveries to MDC have already been made. Meaning several deliveries already. Then thor also has a number of other partners they most likely have delivered to in addition, could it be that they have a better ramp-up than planned? That remains to be seen..You come with some good questions but no answers, but the questions are an important point for Thor Medical's future. Here below is what I have been able to find regarding their capacity: Right now, Thor Medical has about 25 % vacant space left in the first phase of their new factory, after having secured their first major customers. But they have made a couple of brilliant moves that mean they do not risk hitting the wall at all if a giant like Eli Lilly suddenly wants an agreement. They have secured extra space in two ways: They built the factory 40 % larger from the start: When management discovered how large the demand was, they expanded the factory immediately right in the middle of construction. This means that they have a solid buffer standing ready for new customers. The factory grows all by itself because Thor Medical's technology is arranged so smartly that as the raw material "Thorium" lies and works over time, the factory's production increases completely automatically. The output actually grows from 21,000 doses a year to 35,000 doses after 5 years – completely without them having to rebuild or spend more money. They can easily build more factories if a giant like Eli Lilly places an order that is so enormous that the factory in Norway cannot keep up. So there is plenty of space in the shop, and the machinery is geared to welcome the big boys in the class from day one. It is good news that management has taken into account to avoid internal bottlenecks. https://www.thormedical.com/artikler/thor-medical-asa-first-half-2026-results---alphaone-operational-entering-commercial-ramp-up
- ·2 t sittenThor makes haste slowly, bought at 4.10 yesterday, bought with an equally light hand at 4.26 today. Supports a previous post here that mentioned that all purchases in the 4s will entail marginal risk..BUT that assumes one possesses the new superpower..Thormodiness ☝️ (It should really go without saying if you look at my portfolio, but mentioning it anyway, the above must not be seen as a recommendation to buy 😅)Spm: Will we be able to experience DNB changing its target price and recommendation without positive news having been communicated regarding the USA case? What would in that case be the triggering factor? (Asking for a friend 🫣)
- ·4 t sittenPeople who complain about poor communication and little news should check out the quote that Ballon d'Or winner Harry Kane shared on his insta story. Have a nice day.In the previous interview with Finansavisen, one of the journalists says that breaking into the US is not easy and that it must be a matter of partnerships or the like. Could it be that they are playing their cards close to their chest until this is 100% or that they have underestimated the complexity of breaking into the US? Betting on the first. At the end of the day it does not matter all that much, but they need to get to Boston shortly.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä |
|---|---|---|
| 3 193 | ||
| 1 | ||
| 4 695 | ||
| 1 | ||
| 1 880 |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Rahastoja ja ETF:iä jotka omistavat osaketta
Mikään rahasto ei ilmoita osaketta kymmenen suurimman omistuksensa joukossa.
Asiakkaat katsoivat myös
Yhtiötapahtumat
Datan lähde: Quartr| Seuraava tapahtuma | |
|---|---|
2026 H2 - tulosraportti 26.2.2027 |
| Menneet tapahtumat | ||
|---|---|---|
2026 H1 - tulosraportti 28.8. | ||
2025 H2 - tulosraportti 26.2. | ||
2025 H1 - tulosraportti 29.8.2025 | ||
2024 H2 - tulosraportti 26.2.2025 | ||
2024 H1 - tulosraportti 30.8.2024 |
Tuotteita joiden kohde-etuutena tämä arvopaperi
Välittäjätilasto
Dataa ei löytynyt
2026 H1 - tulosraportti
60 päivää sitten
‧45 min
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Yhtiötapahtumat
Datan lähde: Quartr| Seuraava tapahtuma | |
|---|---|
2026 H2 - tulosraportti 26.2.2027 |
| Menneet tapahtumat | ||
|---|---|---|
2026 H1 - tulosraportti 28.8. | ||
2025 H2 - tulosraportti 26.2. | ||
2025 H1 - tulosraportti 29.8.2025 | ||
2024 H2 - tulosraportti 26.2.2025 | ||
2024 H1 - tulosraportti 30.8.2024 |
Tuotteita joiden kohde-etuutena tämä arvopaperi
Foorumi
Liity keskusteluun Nordnet Socialissa
- ·23 min sittenLast time I jump into a Rights Issue. Glad I only got 1/3 of the ones I wanted. Good figures in February must mean an upward trend. Think Thor has complete control. Break Even 2027:)
- ·1 t sitten · MuokattuIt stated in the press release that the first deliveries to MDC have already been made. Meaning several deliveries already. Then thor also has a number of other partners they most likely have delivered to in addition, could it be that they have a better ramp-up than planned? That remains to be seen..You come with some good questions but no answers, but the questions are an important point for Thor Medical's future. Here below is what I have been able to find regarding their capacity: Right now, Thor Medical has about 25 % vacant space left in the first phase of their new factory, after having secured their first major customers. But they have made a couple of brilliant moves that mean they do not risk hitting the wall at all if a giant like Eli Lilly suddenly wants an agreement. They have secured extra space in two ways: They built the factory 40 % larger from the start: When management discovered how large the demand was, they expanded the factory immediately right in the middle of construction. This means that they have a solid buffer standing ready for new customers. The factory grows all by itself because Thor Medical's technology is arranged so smartly that as the raw material "Thorium" lies and works over time, the factory's production increases completely automatically. The output actually grows from 21,000 doses a year to 35,000 doses after 5 years – completely without them having to rebuild or spend more money. They can easily build more factories if a giant like Eli Lilly places an order that is so enormous that the factory in Norway cannot keep up. So there is plenty of space in the shop, and the machinery is geared to welcome the big boys in the class from day one. It is good news that management has taken into account to avoid internal bottlenecks. https://www.thormedical.com/artikler/thor-medical-asa-first-half-2026-results---alphaone-operational-entering-commercial-ramp-up
- ·2 t sittenThor makes haste slowly, bought at 4.10 yesterday, bought with an equally light hand at 4.26 today. Supports a previous post here that mentioned that all purchases in the 4s will entail marginal risk..BUT that assumes one possesses the new superpower..Thormodiness ☝️ (It should really go without saying if you look at my portfolio, but mentioning it anyway, the above must not be seen as a recommendation to buy 😅)Spm: Will we be able to experience DNB changing its target price and recommendation without positive news having been communicated regarding the USA case? What would in that case be the triggering factor? (Asking for a friend 🫣)
- ·4 t sittenPeople who complain about poor communication and little news should check out the quote that Ballon d'Or winner Harry Kane shared on his insta story. Have a nice day.In the previous interview with Finansavisen, one of the journalists says that breaking into the US is not easy and that it must be a matter of partnerships or the like. Could it be that they are playing their cards close to their chest until this is 100% or that they have underestimated the complexity of breaking into the US? Betting on the first. At the end of the day it does not matter all that much, but they need to get to Boston shortly.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä |
|---|---|---|
| 3 193 | ||
| 1 | ||
| 4 695 | ||
| 1 | ||
| 1 880 |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Rahastoja ja ETF:iä jotka omistavat osaketta
Mikään rahasto ei ilmoita osaketta kymmenen suurimman omistuksensa joukossa.
Asiakkaat katsoivat myös
Välittäjätilasto
Dataa ei löytynyt